Correlation Between Ensysce Biosciences and Petros Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Ensysce Biosciences and Petros Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ensysce Biosciences and Petros Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ensysce Biosciences and Petros Pharmaceuticals, you can compare the effects of market volatilities on Ensysce Biosciences and Petros Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ensysce Biosciences with a short position of Petros Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ensysce Biosciences and Petros Pharmaceuticals.

Diversification Opportunities for Ensysce Biosciences and Petros Pharmaceuticals

-0.49

Correlation Coefficient

Ensysce Biosciences  Petros Pharmaceuticals

Very good diversification

The 3 months correlation between Ensysce and Petros is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Ensysce Biosciences and Petros Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Petros Pharmaceuticals and Ensysce Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ensysce Biosciences are associated (or correlated) with Petros Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Petros Pharmaceuticals has no effect on the direction of Ensysce Biosciences i.e., Ensysce Biosciences and Petros Pharmaceuticals go up and down completely randomly.

Pair Corralation between Ensysce Biosciences and Petros Pharmaceuticals

Given the investment horizon of 90 days Ensysce Biosciences is expected to under-perform the Petros Pharmaceuticals. In addition to that, Ensysce Biosciences is 1.5 times more volatile than Petros Pharmaceuticals. It trades about -0.22 of its total potential returns per unit of risk. Petros Pharmaceuticals is currently generating about 0.06 per unit of volatility. If you would invest  26.00  in Petros Pharmaceuticals on September 17, 2024 and sell it today you would earn a total of  1.22  from holding Petros Pharmaceuticals or generate 4.69% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	95.24%
Values	Daily Returns

Ensysce Biosciences  vs.  Petros Pharmaceuticals

Ensysce Biosciences

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Ensysce Biosciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent basic indicators, Ensysce Biosciences exhibited solid returns over the last few months and may actually be approaching a breakup point.

Petros Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Petros Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Ensysce Biosciences and Petros Pharmaceuticals

The main advantage of trading using opposite Ensysce Biosciences and Petros Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ensysce Biosciences position performs unexpectedly, Petros Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Petros Pharmaceuticals will offset losses from the drop in Petros Pharmaceuticals' long position.

The idea behind Ensysce Biosciences and Petros Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.